Oral News and Research

RSS

Do-it-yourself cheek swab tested as next best thing to detect coronavirus

Coronavirus testing is commonly an unpleasant, even painful experience in which a health care provider pushes a torturously long swab up your nostril. President Donald Trump declared that submitting to the process was "a little bit difficult."

2 May 2020

Venatorx and GARDP collaborate to accelerate development of new antibiotic

Venatorx Pharmaceuticals and the Global Antibiotic Research and Development Partnership (GARDP) today announced a collaboration to accelerate the development of, and access to, cefepime-taniborbactam (formerly cefepime/VNRX-5133).

29 Apr 2020

Immune-regulating drug reverses dental problems in aging mice

A drug that has life-extending effects on mice also reverses age-related dental problems in the animals, according to a new study published today in eLife.

28 Apr 2020

New drug formulation could be used in the treatment of Candida infections

With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections.

28 Apr 2020

The approved dose of ivermectin alone not useful in treating COVID-19

A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.

27 Apr 2020

SARS-CoV-2 readily infects human intestinal cells in a laboratory model

A new Dutch study available on bioRxiv uses differentiated human small intestinal organoids in vitro to demonstrate that intestinal epithelium supports the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and elicits a strong generic immune response.

27 Apr 2020

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

27 Apr 2020

Oncologist and mum-to-be chronicles COVID-19 experiences

Writing in the latest issue of JAMA Oncology researcher Coral Olazagasti along with her Dr. Nagashree Seetharamu from Zucker School of Medicine at Hofstra, Northwell Health, Hempstead, New York, spoke about her experience being pregnant during the present COVID-19 pandemic. Olazagasti’s chronicle is titled “Facing a pandemic while pregnant.”

26 Apr 2020

Research Luxembourg launches Predi-COVID study

The Research Luxembourg COVID-19 task force announces the start of "Predi-COVID", a study that aims to identify important risk factors and biomarkers associated with COVID-19 severity and long-term health consequences of the disease in Luxembourg.

24 Apr 2020

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Before being halted due to the COVID-19 pandemic, a relentless vaccination campaign had nearly succeeded in eradicating polio from the world.

24 Apr 2020

Study identifies key nose cells as likely COVID-19 virus entry points

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

23 Apr 2020

Majority of Colorado’s APCs are interested in medication abortion training

Researchers at the University of Colorado Anschutz Medical Campus have found that interest in abortion care among advance practice clinicians (APCs) in Colorado is substantial, though barriers must be addressed in order to increase access with APCs (nurse practitioners, nurse midwives, physician's assistants).

23 Apr 2020

Lifting the lid on coronavirus flatulence

The highly infectious virus is spread via aerosols (droplets of saliva or nasal discharge spread by coughing or sneezing by the infected person with the mouth uncovered). New speculation reveals that it could spread via fecal matter and even via farts or flatulence. Researchers believe that there is some truth to this speculation.

22 Apr 2020

Majority of women prefer LAI HIV therapy over daily pills

A new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over current daily pills.

22 Apr 2020

New study may offer a breakthrough in treating telomere diseases

Capping decades of research, a new study may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely.

21 Apr 2020

Six novel coronaviruses found in bats

While the world grapples with the pandemic, which has spread to 185 countries and territories, infecting more than 2.15 million people and killing more than 143,000 people, a team of researchers at the Smithsonian's Global Health Program has found six novel coronaviruses in bats in Myanmar.

16 Apr 2020

NYU Dentistry receives $2.2 million grant to study role of Schwann cells in oral cancer

The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, has awarded NYU College of Dentistry's Yi Ye, PhD, a $2.2 million, five-year grant to study the role of Schwann cells, the most prevalent type of cell supporting neurons in the peripheral nervous system, in oral cancer progression and pain.

16 Apr 2020

Entamoeba gingivalis linked to severe and recurrent periodontitis

For the first time, researchers from Charité - Universitätsmedizin Berlin have shown that a unicellular parasite commonly found in the mouth plays a role in both severe tissue inflammation and tissue destruction.

16 Apr 2020

Alzheimer's patients may need modified dosing regimens for selected drugs

Patients with Alzheimer's disease are often prescribed drugs for other conditions -- including diabetes or high blood pressure -- at the same doses as those without dementia.

15 Apr 2020

Coronavirus able to survive near boiling point of water, study shows

A startling paper by a team of French scientists published in the preprint journal bioRxiv in April 2020 suggests that the novel coronavirus is capable of surviving at high temperatures. This could mean that laboratory technicians handling the virus are at danger of infection.

15 Apr 2020